Summary
Danaher Corporation (DHR) announced on November 13, 2019, an expansion of its Board of Directors, increasing its size from eleven to thirteen members. This strategic move includes the appointment of two new directors, Jessica L. Mega, MD, MPH, and Pardis C. Sabeti, MD, D.Phil. Both new directors have been appointed to fill the newly created vacancies and will serve until the 2020 annual meeting of shareholders. These appointments are significant as they bring new expertise to the board. Both Dr. Mega and Dr. Sabeti have been determined to be independent directors, meeting the New York Stock Exchange listing standards. As non-employee directors, they will receive standard compensation, including a prorated equity award, aligning them with the company's existing non-employee director compensation structure. Their appointments signal a potential strengthening of the board's governance and oversight capabilities.
Key Highlights
- 1Danaher Corporation expanded its Board of Directors from 11 to 13 members.
- 2Jessica L. Mega, MD, MPH, and Pardis C. Sabeti, MD, D.Phil, were appointed as new directors.
- 3The new directors will serve until Danaher's 2020 annual meeting of shareholders.
- 4Both Dr. Mega and Dr. Sabeti have been deemed independent directors by NYSE standards.
- 5New directors will receive standard compensation for non-employee directors, including a prorated equity award.
- 6There are no undisclosed arrangements or transactions requiring disclosure for the new appointees.